Avelumab Plus 5-FU Based Chemotherapy as Adjuvant Treatment for Stage 3 MSI-High or POLE Mutant Colon Cancer

Clinical trial NCT03827044 · TERMINATED

Trial details

NCT number: NCT03827044
Sponsor: Royal Marsden NHS Foundation Trust
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

POLE Exonuclease Mutant Colon Cancer Microsatellite Instability Stage III Colon Cancer

Start date: 2018-08-31
Primary completion: 2021-01-05
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.